Delivery Order SPE2DB24D1021-SPE2DB25FFALC
- Not listed
- The Defense Logistics Agency awarded a $1,358.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 gm powder packets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $4,074.30 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Veltassa 8.4 GM powder packets (30 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,863.59 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Veltassa 8.4 GM Powder Packet in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of September 11, 2025, and was awarded competitively without set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 10, 2025, for Veltassa 8.4 GM powder packets (30-count) with a ceiling value of $2,037.15 under firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $1,424.40 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). This is a firm fixed price contract with an ultimate completion date of September 5, 2025, and represents a non-set-aside, competitively awarded transaction. The contract is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Veltassa is a potassium-binding agent used in the...
- The Defense Logistics Agency awarded a $7,533.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Veltassa 8.4 GM Powder Packet in a quantity of 30 units, with a ceiling value of $2,716.20. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM Powder Packet in quantities of 30, with a contract value of $8,148.60. Veltassa is a pharmaceutical treatment used in potassium management. This competitively awarded, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,636.48 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). The contract, classified as firm fixed price with no set-aside designation, is scheduled for ultimate completion by July 28, 2025. This delivery order is performed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a $3,988.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). This is a non-set-aside contract with performance at the contractor's corporate office location in Conshohocken, Pennsylvania, and an ultimate completion date of September 12, 2025. Veltassa is a potassium-binding pharmaceutical used in the management of hyperkalemia, a common concern in military and...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFALCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,987.14 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of September 10, 2025. The award was issued on September 9, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion vehicle running through December 2026 that serves as the primary pharmaceutical support mechanism for military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Veltassa, a potassium-binding medication used in the treatment of hyperkalemia, represents the type of specialized pharmaceutical product the company routinely delivers through its extensive federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 9/9/25 |